// App-Quantinova.ai

: Durable Remissions Achieved with R-CHOP Chemotherapy without Radiotherapy in Patients with Primary Mediastinal B-Cell Lymphoma - the Royal Marsden Experience

Researchers

Presenter

  • Vasiliki Michalarea

Principal Investigators

  • Dima El-Sharkawi

  • Siraj Yusuf

  • Mary Gleeson

  • Laura Hickmott

  • Andrew Wotherspoon

  • Ayoma Attygalle

  • Simon O'Connor

  • Bhupinder Sharma

  • Yong Du

  • Imene Zerizer

  • Alan Horwich

  • Gillian Ross

  • Andrea Kuhnl

  • Sunil Iyengar

  • Ian Chau

  • David Cunningham

Medical Centers

  • GI and Lymphoma Unit, The Royal Marsden NHS Foundation Trust, London, United Kingdom

  • Department of Physics, Royal Marsden NHS Foundation Trust, London, United Kingdom

  • Department of Physics, Royal Marsden NHS Foundation Trust, London, United Kingdom

  • Department of Physics, Royal Marsden NHS Foundation Trust, London, United Kingdom

  • Department of Physics, Royal Marsden NHS Foundation Trust, London, United Kingdom

  • Department of Haematology, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • B cell lymphomas

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT01599559

Sponsors

  • N/A

Result

  • N/A